NASDAQ: CRBU

Caribou Biosciences, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Caribou Biosciences, Inc. (NASDAQ: CRBU): (i) pursuant and/or traceable to the offering documents and related prospectus issued in connection with the Company’s 2021 initial public offering conducted on or about July 23, 2021 (the “IPO” or “Offering”); and/or (ii) between July 23, 2021 and December 9, 2022, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2023.

If you purchased Caribou securities and would like to join the action, please click “Join This Class Action.”

集体诉讼期:Pursuant and/or traceable to the Company's July 23, 2021 IPO and/or July 23, 2021 through December 9, 2022
If you purchased Caribou securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

案件详情:

According to the lawsuit, the Offering documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Offering documents and defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:

  • CB-010’s treatment effect was not as durable as defendants had led investors to believe;
  • accordingly, CB-010’s clinical and commercial prospects were overstated; and
  • as a result, the Offering Documents and defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

关注我们:
公司名称: Caribou Biosciences, Inc.
股票代号: CRBU
集体诉讼期: Pursuant and/or traceable to the Company's July 23, 2021 IPO and/or July 23, 2021 through December 9, 2022
法院: United States District Court Northern District of California

为何选择罗森律师事务所?

自 2013 年以来,罗森律师事务所每年都是代表投资者成功提起证券集体诉讼的前四大律所之一。仅 2019 年,本律所就为投资者追回 4.38 亿美元资金。

投资者应仔细鉴别和遴选在引领证券集体诉讼方面有多年成功经验的的律师。通常,其他律所会发布关于集体诉讼的新闻稿,但却没有类似的经验或资源。

机构股东服务公司按 2017 年证券集体诉讼索赔数量,罗森律师事务所列为第一名。

罗森律师事务所为全球投资者提供代理服务。我们的使命是提起证券欺诈集体诉讼以及保护股东的权利。

滚动至顶部